Search Results - "Florin, Floricel"
-
1
Treatment with brivaracetam has no apparent long-term effects on body weight in pediatric patients with epilepsy
Published in Epilepsia open (02-10-2024)“…The objective of this study is to evaluate possible long-term effects of treatment with brivaracetam (BRV) on body weight in children with epilepsy. Post hoc…”
Get full text
Journal Article -
2
Pharmacokinetics and safety of brivaracetam in neonates with repeated electroencephalographic seizures: A multicenter, open‐label, single‐arm study
Published in Epilepsia open (01-04-2024)“…Objective To evaluate the pharmacokinetics (PK), safety, and tolerability of brivaracetam (BRV) in neonates with repeated electroencephalographic seizures not…”
Get full text
Journal Article -
3
Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design
Published in Epilepsia open (01-12-2022)“…Objective Despite introduction of several antiseizure medications over the past two decades, treatment options for childhood absence epilepsy (CAE) and…”
Get full text
Journal Article -
4
2315 12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, multicenter non-interventional EXPERIENCE study
Published in BMJ neurology open (01-08-2022)“…ObjectivesTo evaluate effectiveness and tolerability of brivaracetam (BRV) in routine clinical practice in a large, multicenter, international patient…”
Get full text
Journal Article -
5
Congenital ocular motor apraxia: Clinical and neuroradiological findings, and long-term intellectual prognosis
Published in Brain & development (Tokyo. 1979) (01-08-2007)“…The severity of intellectual sequelae and prognosis varies in patients with congenital ocular motor apraxia (COMA). Here, we explored this phenomenon with…”
Get full text
Journal Article -
6
Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells
Published in Brain & development (Tokyo. 1979) (01-09-2007)“…Tuberous sclerosis complex (TSC) is an autosomal dominant inherited disorder characterized by benign tumors (hamartomas) in various organs. The brain is one of…”
Get full text
Journal Article -
7
Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open‐label exploratory trial
Published in Epilepsia (Copenhagen) (01-11-2023)“…Objective To evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of lacosamide (LCM) (up to 12 mg/kg/day or 600 mg/day) as adjunctive…”
Get full text
Journal Article -
8
Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials
Published in Epilepsia (Copenhagen) (01-08-2022)“…Objective This study was undertaken to evaluate safety/tolerability and efficacy of adjunctive brivaracetam (BRV) in patients on one or two concomitant…”
Get full text
Journal Article -
9
Early Intervention with Midazolam Nasal Spray and Efficacy in Patients with Seizure Clusters: Post-hoc Analysis of an Open-label Extension Trial (P13-8.007)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
10
Time-course of Treatment-emergent Adverse Events Potentially Associated with Behavioral Disorders during Adjunctive Brivaracetam Treatment of Adults with Focal Seizures (P17-8.003)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
11
Cognitive and Behavioral Effects of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Final Data From an Open-label Follow-up Trial (P14-1.007)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article -
12
Cognitive and Behavioral Effects and Tolerability of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Pooled Interim Analysis (P13-8.004)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
13
Efficacy and tolerability of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed temporal lobe epilepsy: Post hoc analysis of a randomized, double-blind trial
Published in Seizure (London, England) (01-11-2023)“…•Post hoc analyses of patients with temporal lobe epilepsy (TLE).•Patients on lacosamide (LCM) or controlled-release carbamazepine (CBZ-CR)…”
Get full text
Journal Article -
14
Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy
Published in Epilepsy & behavior (01-10-2024)“…[Display omitted] •Kaplan-Meier–estimated 1-year retention on lacosamide (LCM) was high (80%).•≥12-month seizure freedom was 29.9 %/24.4 % in…”
Get full text
Journal Article -
15
Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures
Published in Epilepsy & behavior (01-07-2024)“…[Display omitted] •11% on BRV vs. 4.8% on PBO had drug-related psychiatric/behavioral (P/B) TEAEs.•Most patients had mild/moderate P/B TEAEs and did not…”
Get full text
Journal Article -
16
Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open‐label, follow‐up trial
Published in Epilepsia (Copenhagen) (01-11-2023)“…Objective This study was undertaken to evaluate the long‐term safety, tolerability, and efficacy of adjunctive brivaracetam (BRV) treatment in pediatric…”
Get full text
Journal Article -
17
12-month Effectiveness and Tolerability of Brivaracetam in Patients with Epilepsy and Cognitive or Psychiatric Comorbidities: Subgroup Data from the International EXPERIENCE Pooled Analysis (P8-1.009)
Published in Neurology (09-04-2024)“…Abstract only…”
Get full text
Journal Article -
18
12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis (P11-1.003)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article -
19
12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, non-interventional EXPERIENCE study (P13-8.002)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
20
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records
Published in CNS drugs (01-09-2023)“…Background and Objective Real-world evidence studies of brivaracetam (BRV) have been restricted in scope, location, and patient numbers. The objective of this…”
Get full text
Journal Article